• 447 Citations
  • 12 h-Index
19962019
If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Masayuki Hashiguchi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 4 Similar Profiles
Japan Medicine & Life Sciences
Drug-Related Side Effects and Adverse Reactions Medicine & Life Sciences
Adverse Drug Reaction Reporting Systems Medicine & Life Sciences
Methotrexate Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Rheumatoid Arthritis Medicine & Life Sciences
Meta-Analysis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

  • 447 Citations
  • 12 h-Index
  • 55 Article
  • 3 Review article

Comparing torsemide versus furosemide in patients with heart failure: A meta-analysis

Kido, K., Shimizu, M. & Hashiguchi, M., 2019 May 1, In : Journal of the American Pharmacists Association. 59, 3, p. 432-438 7 p.

Research output: Contribution to journalReview article

torsemide
Furosemide
Meta-Analysis
Heart Failure
Cardiovascular Diseases
2 Citations (Scopus)

Long-term effect of NUDT15 R139C on hematologic indices in inflammatory bowel disease patients treated with thiopurine

Akiyama, S., Matsuoka, K., Fukuda, K., Hamada, S., Shimizu, M., Nanki, K., Mizuno, S., Kiyohara, H., Arai, M., Sugimoto, S., Iwao, Y., Ogata, H., Hisamatsu, T., Naganuma, M., Motobayashi, M., Suzuki, K., Takenaka, K., Fujii, T., Saito, E., Nagahori, M. & 5 others, Ohtsuka, K., Mochizuki, M., Watanabe, M., Hashiguchi, M. & Kanai, T., 2019 Jan 1, In : Journal of Gastroenterology and Hepatology (Australia).

Research output: Contribution to journalReview article

Inflammatory Bowel Diseases
Erythrocyte Indices
Leukopenia
Leukocyte Count
Genotype
1 Citation (Scopus)

Factors predicting the therapeutic response to infliximab during maintenance therapy in Japanese patients with Crohn's disease

Matsuoka, K., Hamada, S., Shimizu, M., Nanki, K., Mizuno, S., Kiyohara, H., Arai, M., Sugimoto, S., Iwao, Y., Ogata, H., Hisamatsu, T., Naganuma, M., Kanai, T., Mochizuki, M. & Hashiguchi, M., 2018 Oct 1, In : PLoS One. 13, 10, e0204632.

Research output: Contribution to journalArticle

Crohn disease
Crohn Disease
tumor necrosis factors
therapeutics
Tumor Necrosis Factor-alpha

Factors predicting the therapeutic response to methotrexate in Japanese patients with rheumatoid arthritis: A hospital-based cohort study

Hakamata, J., Kaneko, Y., Shimizu, M., Yamaoka, K., Maruyama, J., Takeuchi, T., Mochizuki, M. & Hashiguchi, M., 2018 Jan 1, In : Biological and Pharmaceutical Bulletin. 41, 9, p. 1414-1422 9 p.

Research output: Contribution to journalArticle

Methotrexate
Rheumatoid Arthritis
Cohort Studies
Therapeutics
Genotype

Risk Factor for Diabetes Mellitus and High Blood Glucose With HMG-CoA Reductase Inhibitors Using a Postmarketing Surveillance Database in Japan

Hashiguchi, M., Maruyama, J., Shimizu, M., Takahashi, D. & Shiga, T., 2018 Jan 1, (Accepted/In press) In : Clinical Pharmacology in Drug Development.

Research output: Contribution to journalArticle

Hydroxymethylglutaryl-CoA Reductase Inhibitors
Blood Glucose
Diabetes Mellitus
Japan
Databases